BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3920969)

  • 21. Verapamil inhibition of vasopressin-stimulated water flow: possible role of intracellular calcium.
    Burch RM; Halushka PV
    J Pharmacol Exp Ther; 1983 Sep; 226(3):701-5. PubMed ID: 6411896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
    Fitzpatrick SL; LaChance MP; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of adenosine transport by verapamil and other calcium channel antagonists.
    Rovetto MJ; Ford DA
    Prog Clin Biol Res; 1987; 230():223-33. PubMed ID: 3588598
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentiation by a biscoclaurine alkaloid, cepharanthine, of the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin in HeLa cells.
    Shiraishi N; Shimada T; Hagino Y; Kohno K; Kobayashi M; Kuwano M; Akiyama S
    Cancer Res; 1988 Mar; 48(5):1307-11. PubMed ID: 3257717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of calcium-channel-blocking drugs on lysosomal function in human skin fibroblasts.
    Ranganathan S; Jackson RL
    Biochem Pharmacol; 1984 Aug; 33(15):2377-82. PubMed ID: 6466359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate.
    Seth P; Fitzgerald DJ; Willingham MC; Pastan I
    J Virol; 1984 Sep; 51(3):650-5. PubMed ID: 6332200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stabilizing action of verapamil "in vivo" upon the membrane of heart lysosomes (author's transl)].
    Rodrigues LE; Pinto G; Pinto R; Machado AE
    Rev Bras Pesqui Med Biol; 1977 Dec; 10(6):407-10. PubMed ID: 609776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines.
    Chauhan SS; Liang XJ; Su AW; Pai-Panandiker A; Shen DW; Hanover JA; Gottesman MM
    Br J Cancer; 2003 Apr; 88(8):1327-34. PubMed ID: 12698203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation analysis of the neutral and protonated forms of gallopamil (D600).
    Deleers M; Brasseur R; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):320-1. PubMed ID: 7181590
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of concentration on hepatic transport of exogenous epidermal growth factor.
    Burwen SJ; Barker ME; Goldman IS; Jones AL
    Hepatology; 1985; 5(2):211-4. PubMed ID: 3872251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor.
    Seth P; Fitzgerald D; Ginsberg H; Willingham M; Pastan I
    Mol Cell Biol; 1984 Aug; 4(8):1528-33. PubMed ID: 6333584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of epidermal growth factor on protein degradation the translocation of non-histone proteins to the nucleus and DNA synthesis.
    Polet H; Fryxell D
    Biochim Biophys Acta; 1989 Oct; 1013(3):279-86. PubMed ID: 2804088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new mechanism of lipotoxicity: Calcium channel blockers as a treatment for nonalcoholic steatohepatitis?
    Czaja MJ
    Hepatology; 2015 Jul; 62(1):312-4. PubMed ID: 25904459
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidermal growth factor: lysosomal degradation is not involved in the initial mitogenic signal to the nucleus.
    Inzani VA
    Biochem Soc Trans; 1990 Jun; 18(3):446. PubMed ID: 2373235
    [No Abstract]   [Full Text] [Related]  

  • 35. [Augmented lysosomal chain-reaction cytolysis through the temporary increase of lysosome content in cancerous cells].
    von Ardenne M
    Naturwissenschaften; 1970 Jul; 57(7):360-1. PubMed ID: 5432542
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of calcium antagonists on intracellular transport of epidermal growth factor and the conjugate of epidermal growth factor with pseudomonas exotoxin].
    Akiyama S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):660-8. PubMed ID: 3920969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin.
    Akiyama S; Gottesman MM; Hanover JA; Fitzgerald DJ; Willingham MC; Pastan I
    J Cell Physiol; 1984 Sep; 120(3):271-9. PubMed ID: 6086678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of calcium antagonists on the proteolytic degradation of low-density lipoprotein in HeLa cells.
    Akiyama S; Tomita K; Kuwano M
    Exp Cell Res; 1985 May; 158(1):192-204. PubMed ID: 3888644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes.
    Elferink JG
    Arzneimittelforschung; 1982; 32(11):1417-20. PubMed ID: 6891245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates.
    Lyall RM; Hwang JL; Cardarelli C; FitzGerald D; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1987 Jun; 47(11):2961-6. PubMed ID: 3494506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.